Altered ventricular longitudinal strain in children with sickle cell disease: Role of TGF-β and IL-18

Reham Wagdy1, Hala Assem1, Ali M Abd-Elmohsen1

  • 1Department of Pediatrics, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Pediatric Blood & Cancer
|November 7, 2023
PubMed

Insights

Transforming growth factor beta (TGF-β) and interleukin-18 (IL-18) show promise as biomarkers for sickle cell cardiomyopathy in children. Elevated levels correlate with altered cardiac strain, indicating potential subclinical heart damage.

Area of Science:

  • Cardiology
  • Pediatrics
  • Hematology

Background:

  • Cardiovascular complications significantly impact morbidity and mortality in sickle cell disease (SCD).
  • Interleukin-18 (IL-18) and transforming growth factor beta (TGF-β) are emerging as potential biomarkers for sickle cell cardiomyopathy.
  • Global longitudinal strain (GLS) is a key indicator of myocardial deformation.

Purpose of the Study:

  • To investigate the role of TGF-β and IL-18 as risk indicators for altered cardiac strain in children with SCD.
  • To assess the correlation between these biomarkers and echocardiographic parameters of cardiac function.

Main Methods:

  • A study involving 40 children with SCD and 40 age- and sex-matched healthy controls.
  • Assessment included clinical examination, complete blood count, serum ferritin, TGF-β, IL-18 levels, and echocardiography for cardiac function.

Main Results:

  • TGF-β, IL-18, and LDH levels were significantly elevated in children with SCD compared to controls.
  • Right ventricular free wall longitudinal strain (FWLS-RV) was significantly reduced in SCD patients.
  • FWLS-RV correlated with IL-18 and LDH, while GLS-RV correlated with TGF-β. GLS-LV correlated with vaso-occlusive crises (VOCs).

Conclusions:

  • TGF-β, IL-18, and LDH, along with frequent VOCs, are associated with altered longitudinal strain, particularly in the right ventricle.
  • These markers may serve as indicators for subclinical cardiomyopathy in pediatric SCD patients.
Abstract